Our top stories this month—one about the 2023 MPFS, another about social media's impact on business—show that money is on everyone’s mind right now. Readers have also been focused on innovation. Just look at the popularity of stories about a surgical breakthrough, the PRECISE trial and tricuspid valve replacement.

I can't wait to see which stories stand out in December. For now, though, I need to go. I have a 10-foot inflatable Santa Claus to set up in the front yard. Thanks for reading!  

Michael Walter | Editor | Cardiovascular Business

The American College of Cardiology and Heart Rhythm Society issued a joint statement soon after CMS published its final rule for the 2023 Medicare Physician Fee Schedule. The groups warned that the final rule could threaten patient access to high-quality care. 

Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly's CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 

Two specialists with Hackensack University Medical Center in New Jersey performed the procedure. The patient, a 71-year-old woman, is doing well. 

Former U.S. Surgeon General Jerome Adams spoke at the AHA 2022 Scientific Sessions and asked cardiologists to help end the COVID pandemic and tackle the even bigger epidemic of hypertension.

James Udelson, MD, an investigator involved with the PRECISE trial, explained how patient outcomes were improved by 70% from the current standard of care.

The risk of developing vaccine-related myocarditis, pericarditis or myopericarditis remains very low, researchers wrote. 

The new findings, presented at the PCR London Valves 2022 conference, focused on mortality and heart failure hospitalization rates. 

Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients. 

The companies were given 15 days to provide an adequate response to the FDA's warning. The agency said its next step could include legal action. 

Low HDL-C levels are commonly associated with increasing a person's risk of developing cardiovascular disease. However, a new study in the Journal of the American College of Cardiology suggests this may not be the case for all patient populations.